 Home > Medical News > Latest Medical News > my country's recombinant protein new coronavirus vaccine clinical trial results released

my country's recombinant protein new coronavirus vaccine clinical trial results released

 Last Update: 2021-04-13
 Source: Internet
 Author: User

Tags

new products

iodine medical use

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Results of Phase I and Phase II Clinical Trials of my country's Recombinant Protein New Coronavirus Vaccine Released

my country's recombinant protein neocoronavirus vaccine phase I and phase II clinical trial results released my country's recombinant protein neocoronavirus vaccine phase I and phase II clinical trial results released

Xinhua News Agency, Beijing, March 26 (Reporters Ruifeng Dong and Haitao Xu) China has approved a recombinant protein subunit new coronavirus vaccine for emergency use.

Knife · Infectious Diseases" released.

Academy of Sciences

According to reports, a total of 950 healthy adults between the ages of 18 and 59 were recruited in the two domestic clinical trials of the vaccine, using a randomized, double-blind, and placebo-controlled trial protocol.

The results showed that no serious vaccine-related adverse events occurred.

Currently, the vaccine is undergoing international multi-center phase III clinical trials in Uzbekistan, Indonesia, Pakistan and Ecuador, and was approved for registration in Uzbekistan on March 1.

Recombinant protein subunit vaccines express and purify pathogen antigen proteins in engineered cells through genetic engineering, and then prepare them into vaccines.

Up to now, my country has 4 new coronavirus vaccines on the market conditionally, and one new coronavirus vaccine has been approved for emergency use.

aspx?id=3570" style="color:#ba1413" target="_blank">Focus on the new crown pneumonia epidemic

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.